首页 > 最新文献

Pain physician最新文献

英文 中文
Letter to CMS on Physician Payment Reform regarding CMS1832P. 致CMS关于CMS1832P医师薪酬改革的信
IF 2.5 2区 医学 Q2 ANESTHESIOLOGY Pub Date : 2025-12-01
Laxmaiah Manchikanti, Mahendra Sanapati
{"title":"Letter to CMS on Physician Payment Reform regarding CMS1832P.","authors":"Laxmaiah Manchikanti, Mahendra Sanapati","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":19841,"journal":{"name":"Pain physician","volume":"28 S7","pages":"S220-S227"},"PeriodicalIF":2.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145892724","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In Response to: Request for Withdrawal of Publication of "Rapid Recommendations by Busse et al of Commonly Used Interventional Procedures for Non-Cancer Chronic Spine Pain: A Clinical Practice Guidelines". 为回应:撤回《由Busse等人对非癌症慢性脊柱疼痛常用介入手术的快速推荐:临床实践指南》的发表请求。
IF 2.5 2区 医学 Q2 ANESTHESIOLOGY Pub Date : 2025-12-01
Helen Macdonald
{"title":"In Response to: Request for Withdrawal of Publication of \"Rapid Recommendations by Busse et al of Commonly Used Interventional Procedures for Non-Cancer Chronic Spine Pain: A Clinical Practice Guidelines\".","authors":"Helen Macdonald","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":19841,"journal":{"name":"Pain physician","volume":"28 S7","pages":"S219"},"PeriodicalIF":2.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145892636","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Feasibility and Safety of Treatment of Painful Lumbar Degenerative Disc Disease with an Injectable Hydrogel Implant at One-year Follow-up. 可注射水凝胶植入治疗疼痛性腰椎间盘退变性疾病一年随访的可行性和安全性。
IF 2.5 2区 医学 Q2 ANESTHESIOLOGY Pub Date : 2025-12-01
Olivier Clerk-Lamalice, Alfonso Spath, Kimberly Carcary, Kasra Amirdelfan, Pierce D Nunley, Douglas P Beall
<p><strong>Background: </strong>Degenerative disc disease (DDD) is the most common cause of chronic low back pain (CLBP). In DDD, proteoglycans within the nucleus pulposus break down and lose their ability to retain water, thereby reducing the volume of intervertebral discs and decreasing their weight-bearing capacity. Mechanical loading shifts to the annulus fibrosus, creating fissures and tears that leak crucial factors in the pain to cascade into the intradiscal space and trigger inflammation. When conventional treatments for CLBP fail, surgical options may be required. These surgeries carry risks and require months to heal. For intervertebral discs requiring augmentation, an implant in the form of an injectable, polymer-based hydrogel was developed for the percutaneous treatment of CLBP secondary to lumbar DDD. We hypothesize that the implant's hydrophilic properties will increase water retention and hydration, improve biomechanics, distribute axial loading more evenly across the annulus fibrosus, and reduce some mechanical sources of discogenic disc pain.</p><p><strong>Objective: </strong>To evaluate the safety and efficacy of a novel, injectable hydrogel implant for the treatment of CLBP.</p><p><strong>Study design: </strong>Prospective, single-arm, multicenter feasibility and safety study.</p><p><strong>Methods: </strong>Patients with CLBP lasting for longer than 6 months, DDD (modified Pfirrmann grades 4-8), competent outer annuli, numeric rating scale (NRS) scores >= 4, and Oswestry Disability Index (ODI) scores >= 30 were enrolled in 3 outpatient clinics in Canada and Colombia. The hydrogel implant, melted and equilibrated to 65°C, was injected intradiscally with a 17G needle under local anesthesia, using fluoroscopic guidance. The hydrogel cooled to approximately 42°C as it exited the needle directly into the nucleus. Patients were discharged that day. Clinical assessments included ODI and NRS (taken at one, 3, 6, and 12 months), radiographs, computed tomography, and magnetic resonance imaging (MRI) scans. The primary outcome was the successful insertion  of the implant in a lumbar disc nucleus.</p><p><strong>Results: </strong>Sixty patients (36 women, 24 men), 49.0 ± 9.3 years old, received 83 implants (one disc-level: n = 37; 2 disc-levels: n = 23). All patients were implanted successfully without complications during the procedure or at discharge. One patient died (for reasons unrelated to the device/procedure), and one patient was lost to follow-up, for n = 58 at the 12-month follow-up. Five patients (8.6%) experienced increased low back pain (LBP) or leg pain and/or leg paresthesia, due to what radiological procedures confirmed was partial implant migration. Migrated implant portions were removed endoscopically from those patients 2 weeks to 10 months after implantation, constituting a 6% (5/83) failure rate. Mean (standard error [SE]) ODI scores in the patients was 9.6 (1.7) at the final follow-up. In the full cohort, ODI scores
背景:椎间盘退行性病变(DDD)是慢性腰痛(CLBP)最常见的原因。在DDD中,髓核内的蛋白聚糖分解并失去保水能力,从而减少椎间盘的体积,降低其承重能力。机械负荷转移到纤维环,造成裂缝和撕裂,将疼痛的关键因素泄漏到椎间盘内间隙并引发炎症。当常规治疗CLBP失败时,可能需要手术治疗。这些手术有风险,需要几个月的时间才能痊愈。对于需要增强的椎间盘,开发了一种可注射的聚合物水凝胶形式的植入物,用于经皮治疗继发于腰椎DDD的CLBP。我们假设植入物的亲水特性将增加水潴留和水合作用,改善生物力学,在纤维环上更均匀地分配轴向载荷,并减少椎间盘源性椎间盘疼痛的一些机械来源。目的:评价一种新型可注射水凝胶种植体治疗CLBP的安全性和有效性。研究设计:前瞻性、单臂、多中心可行性和安全性研究。方法:在加拿大和哥伦比亚的3个门诊纳入CLBP持续时间超过6个月,DDD(改良Pfirrmann分级4-8),能力外环,数值评定量表(NRS)评分>= 4,Oswestry残疾指数(ODI)评分>= 30的患者。将水凝胶植入物融化并平衡至65℃,在透视引导下,局部麻醉下用17G针内注射。当水凝胶从针头直接进入细胞核时,它冷却到大约42°C。患者当日出院。临床评估包括ODI和NRS(1、3、6和12个月)、x线片、计算机断层扫描和磁共振成像(MRI)扫描。主要结果是成功地将植入物插入腰椎间盘核。结果:60例患者(女性36例,男性24例),年龄49.0±9.3岁,共植入物83枚(1椎间盘节段:n = 37; 2椎间盘节段:n = 23)。所有患者在手术过程中或出院时均成功植入,无并发症。在12个月的随访中,1例患者死亡(原因与设备/程序无关),1例患者失访,n = 58。5名患者(8.6%)由于放射学检查证实是植入物部分迁移,腰痛(LBP)或腿部疼痛和/或腿部感觉异常加重。这些患者在植入后2周至10个月通过内窥镜切除移位的植入物部分,失败率为6%(5/83)。在最终随访时,患者的平均(标准误差[SE]) ODI评分为9.6(1.7)。在整个队列中,ODI评分从基线平均(SE) 57.4(1.5)改善到1个月时的12.7(1.8)和12个月时的11.2 (2.0)(P < 0.001)。NRS背部疼痛评分在1个月时从基线7.3分(0.2分)提高到2.2分(0.3分),在12个月时从2.1分(0.3分)提高(P < 0.001)。NRS腿部疼痛评分从基线5.5(0.4)改善到1个月时的1.1(0.2)和12个月时的1.4 (0.3)(P < 0.001)。治疗的椎间盘水平的数量与结果无关。局限性:作为一项可行性和安全性研究的固有局限性,包括相对较小的患者队列和缺乏对照组。结论:一种新型的、可注射的、聚合物基水凝胶植入物成功地植入了60例患者的83个椎间盘,有效地治疗了继发性DDD的CLBP。功能、腰痛和下肢疼痛的临床显著改善维持了12个月。
{"title":"Feasibility and Safety of Treatment of Painful Lumbar Degenerative Disc Disease with an Injectable Hydrogel Implant at One-year Follow-up.","authors":"Olivier Clerk-Lamalice, Alfonso Spath, Kimberly Carcary, Kasra Amirdelfan, Pierce D Nunley, Douglas P Beall","doi":"","DOIUrl":"","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Degenerative disc disease (DDD) is the most common cause of chronic low back pain (CLBP). In DDD, proteoglycans within the nucleus pulposus break down and lose their ability to retain water, thereby reducing the volume of intervertebral discs and decreasing their weight-bearing capacity. Mechanical loading shifts to the annulus fibrosus, creating fissures and tears that leak crucial factors in the pain to cascade into the intradiscal space and trigger inflammation. When conventional treatments for CLBP fail, surgical options may be required. These surgeries carry risks and require months to heal. For intervertebral discs requiring augmentation, an implant in the form of an injectable, polymer-based hydrogel was developed for the percutaneous treatment of CLBP secondary to lumbar DDD. We hypothesize that the implant's hydrophilic properties will increase water retention and hydration, improve biomechanics, distribute axial loading more evenly across the annulus fibrosus, and reduce some mechanical sources of discogenic disc pain.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;To evaluate the safety and efficacy of a novel, injectable hydrogel implant for the treatment of CLBP.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Study design: &lt;/strong&gt;Prospective, single-arm, multicenter feasibility and safety study.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;Patients with CLBP lasting for longer than 6 months, DDD (modified Pfirrmann grades 4-8), competent outer annuli, numeric rating scale (NRS) scores &gt;= 4, and Oswestry Disability Index (ODI) scores &gt;= 30 were enrolled in 3 outpatient clinics in Canada and Colombia. The hydrogel implant, melted and equilibrated to 65°C, was injected intradiscally with a 17G needle under local anesthesia, using fluoroscopic guidance. The hydrogel cooled to approximately 42°C as it exited the needle directly into the nucleus. Patients were discharged that day. Clinical assessments included ODI and NRS (taken at one, 3, 6, and 12 months), radiographs, computed tomography, and magnetic resonance imaging (MRI) scans. The primary outcome was the successful insertion  of the implant in a lumbar disc nucleus.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Sixty patients (36 women, 24 men), 49.0 ± 9.3 years old, received 83 implants (one disc-level: n = 37; 2 disc-levels: n = 23). All patients were implanted successfully without complications during the procedure or at discharge. One patient died (for reasons unrelated to the device/procedure), and one patient was lost to follow-up, for n = 58 at the 12-month follow-up. Five patients (8.6%) experienced increased low back pain (LBP) or leg pain and/or leg paresthesia, due to what radiological procedures confirmed was partial implant migration. Migrated implant portions were removed endoscopically from those patients 2 weeks to 10 months after implantation, constituting a 6% (5/83) failure rate. Mean (standard error [SE]) ODI scores in the patients was 9.6 (1.7) at the final follow-up. In the full cohort, ODI scores ","PeriodicalId":19841,"journal":{"name":"Pain physician","volume":"28 S7","pages":"S203-S213"},"PeriodicalIF":2.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145893196","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Request for Withdrawal of Publication of "Rapid Recommendations by Busse et al of Commonly Used Interventional Procedures for Non-Cancer Chronic Spine Pain: A Clinical Practice Guidelines". 请求撤回发表的“由Busse等人提出的非癌症慢性脊柱疼痛常用介入手术的快速建议:临床实践指南”。
IF 2.5 2区 医学 Q2 ANESTHESIOLOGY Pub Date : 2025-12-01
Laxmaiah Manchikanti
{"title":"Request for Withdrawal of Publication of \"Rapid Recommendations by Busse et al of Commonly Used Interventional Procedures for Non-Cancer Chronic Spine Pain: A Clinical Practice Guidelines\".","authors":"Laxmaiah Manchikanti","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":19841,"journal":{"name":"Pain physician","volume":"28 S7","pages":"S215-S218"},"PeriodicalIF":2.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145892866","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Functional Spinal Unit Approach for Orthobiologic Injections for Low Back Pain. 功能性脊柱单元入路治疗下腰痛的骨科注射。
IF 2.5 2区 医学 Q2 ANESTHESIOLOGY Pub Date : 2025-12-01
Annu Navani, Swarnima Vardhan, Abhinav Aggarwal, Riya Navani, Jose Fabio Lana, Sudhir A Diwan
<p><strong>Background: </strong>Low back pain (LBP) is a common and complex health issue with a multifactorial origin, involving structures such as the lumbar intervertebral discs (IVDs), facet joints, muscles, ligaments, and nerve roots. Typically, traditional pain management approaches target isolated pain generators. However, recent advancements, particularly regenerative injection techniques, have shifted the focus toward a more comprehensive treatment model that addresses the entire functional spinal unit (FSU), providing a disease-modifying approach.</p><p><strong>Objectives: </strong>The purpose of this narrative review is to provide a scoping overview of the concept of the FSU and evaluate the potential role of orthobiologics, such as platelet-rich plasma (PRP) and mesenchymal stem cells (MSCs), in treating back pain associated with various spinal conditions.</p><p><strong>Study design: </strong>Narrative literature review.</p><p><strong>Methods: </strong>Relevant peer-reviewed manuscripts were identified through a comprehensive search of electronic databases, such as PubMed, Embase, and Google Scholar. Studies focusing on the anatomy, biomechanics, and pathology of the FSU, as well as those concerning the application of PRP and MSCs in spinal disorders, were included.</p><p><strong>Results: </strong>The FSU, the smallest structural unit of the spine, consists of 2 vertebrae, an IVD, facet joints, and associated supporting ligaments. The FSU is crucial for absorbing shock, distributing mechanical loads, protecting the spinal cord and nerve roots, and maintaining spinal stability and mobility. Orthobiologic therapies, including PRP and MSCs, have shown promise in modulating disease processes and promoting tissue repair in spinal conditions. Emerging evidence supports the efficacy of these therapies in reducing pain and improving functional outcomes by targeting multiple components of the FSU. A thorough understanding of the biomechanical processes and the dynamic distribution of mechanical load across its various structures is essential to recognizing that chronic LBP often arises from multiple pain generators rather than a single source. Therefore, an integrated treatment approach that addresses these multiple pain generators collectively, considering the FSU and the entire spine, is critical for optimizing patient outcomes.</p><p><strong>Limitations: </strong>Rather than being systematic, this narrative review is focused on providing an overview of the effects of orthobiologics in the treatment of chronic LBP using an FSU approach. The heterogeneity of study designs, variability in treatment protocols, and limited long-term data pose challenges in establishing standardized guidelines for orthobiologic therapies in LBP management.</p><p><strong>Conclusions: </strong>Orthobiologic treatments offer a promising disease-modifying approach by addressing the entire FSU rather than isolated pain generators. Future research should focus on optimi
背景:腰痛(LBP)是一种常见而复杂的健康问题,具有多因素的起源,涉及腰椎椎间盘(IVDs)、小关节、肌肉、韧带和神经根等结构。通常,传统的疼痛管理方法针对孤立的疼痛产生源。然而,最近的进展,特别是再生注射技术,已经将焦点转向更全面的治疗模式,解决整个功能脊柱单元(FSU),提供一种疾病改善方法。目的:这篇叙述性综述的目的是提供FSU概念的范围概述,并评估骨科的潜在作用,如富血小板血浆(PRP)和间充质干细胞(MSCs),治疗与各种脊柱疾病相关的背痛。研究设计:叙述性文献综述。方法:通过PubMed、Embase、谷歌Scholar等电子数据库综合检索相关同行评议稿件。包括FSU的解剖、生物力学和病理学研究,以及PRP和MSCs在脊柱疾病中的应用研究。结果:FSU是脊柱最小的结构单元,由2个椎骨、1个IVD、小关节和相关的支撑韧带组成。FSU对于吸收冲击、分配机械负荷、保护脊髓和神经根、维持脊柱的稳定性和活动能力至关重要。包括PRP和MSCs在内的骨科治疗在调节疾病过程和促进脊柱疾病的组织修复方面显示出前景。新出现的证据支持这些疗法通过靶向FSU的多个组成部分来减轻疼痛和改善功能预后的有效性。全面了解生物力学过程和机械负荷在其不同结构中的动态分布对于认识到慢性腰痛通常由多种疼痛源引起而不是单一来源至关重要。因此,考虑到FSU和整个脊柱,综合解决这些多重疼痛产生因素的治疗方法对于优化患者的治疗效果至关重要。局限性:这篇叙述性综述不是系统性的,而是侧重于提供骨科在使用FSU方法治疗慢性下腰痛中的作用的概述。研究设计的异质性、治疗方案的可变性和有限的长期数据为建立规范的矫正生物治疗LBP管理指南带来了挑战。结论:骨科治疗通过解决整个FSU而不是孤立的疼痛产生源,提供了一种有希望的疾病改善方法。未来的研究应侧重于优化多靶点注射策略,从而规范治疗方案。
{"title":"Functional Spinal Unit Approach for Orthobiologic Injections for Low Back Pain.","authors":"Annu Navani, Swarnima Vardhan, Abhinav Aggarwal, Riya Navani, Jose Fabio Lana, Sudhir A Diwan","doi":"","DOIUrl":"","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Low back pain (LBP) is a common and complex health issue with a multifactorial origin, involving structures such as the lumbar intervertebral discs (IVDs), facet joints, muscles, ligaments, and nerve roots. Typically, traditional pain management approaches target isolated pain generators. However, recent advancements, particularly regenerative injection techniques, have shifted the focus toward a more comprehensive treatment model that addresses the entire functional spinal unit (FSU), providing a disease-modifying approach.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objectives: &lt;/strong&gt;The purpose of this narrative review is to provide a scoping overview of the concept of the FSU and evaluate the potential role of orthobiologics, such as platelet-rich plasma (PRP) and mesenchymal stem cells (MSCs), in treating back pain associated with various spinal conditions.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Study design: &lt;/strong&gt;Narrative literature review.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;Relevant peer-reviewed manuscripts were identified through a comprehensive search of electronic databases, such as PubMed, Embase, and Google Scholar. Studies focusing on the anatomy, biomechanics, and pathology of the FSU, as well as those concerning the application of PRP and MSCs in spinal disorders, were included.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;The FSU, the smallest structural unit of the spine, consists of 2 vertebrae, an IVD, facet joints, and associated supporting ligaments. The FSU is crucial for absorbing shock, distributing mechanical loads, protecting the spinal cord and nerve roots, and maintaining spinal stability and mobility. Orthobiologic therapies, including PRP and MSCs, have shown promise in modulating disease processes and promoting tissue repair in spinal conditions. Emerging evidence supports the efficacy of these therapies in reducing pain and improving functional outcomes by targeting multiple components of the FSU. A thorough understanding of the biomechanical processes and the dynamic distribution of mechanical load across its various structures is essential to recognizing that chronic LBP often arises from multiple pain generators rather than a single source. Therefore, an integrated treatment approach that addresses these multiple pain generators collectively, considering the FSU and the entire spine, is critical for optimizing patient outcomes.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Limitations: &lt;/strong&gt;Rather than being systematic, this narrative review is focused on providing an overview of the effects of orthobiologics in the treatment of chronic LBP using an FSU approach. The heterogeneity of study designs, variability in treatment protocols, and limited long-term data pose challenges in establishing standardized guidelines for orthobiologic therapies in LBP management.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;Orthobiologic treatments offer a promising disease-modifying approach by addressing the entire FSU rather than isolated pain generators. Future research should focus on optimi","PeriodicalId":19841,"journal":{"name":"Pain physician","volume":"28 S7","pages":"S145-S156"},"PeriodicalIF":2.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145893204","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Radiofrequency Ablation for Musculoskeletal Pain: A Bibliometric Analysis of Global Research Trends (2000-2024). 肌肉骨骼疼痛的射频消融:全球研究趋势的文献计量学分析(2000-2024)。
IF 2.5 2区 医学 Q2 ANESTHESIOLOGY Pub Date : 2025-12-01
Sahide Eda Artuc, Gizem Kilinc Kamaci
<p><strong>Background: </strong>Radiofrequency ablation (RFA) is a minimally invasive technique increasingly utilized in the treatment of musculoskeletal pain, particularly when pharmacological or rehabilitative approaches prove insufficient. However, the thematic evolution and research development of RFA over the past 2 decades have not been explored adequately.</p><p><strong>Objective: </strong>To conduct a comprehensive bibliometric analysis of the global literature on RFA for musculoskeletal pain, identifying publication trends, research focuses, leading contributors, and thematic transitions between 2000 and 2024.</p><p><strong>Study design: </strong>Bibliometric analysis.</p><p><strong>Setting: </strong>Data were retrieved from the Web of Science Core Collection (WoSCC).</p><p><strong>Methods: </strong>A total of 736 English-language articles published between January 1, 2000, and December 31, 2024, were included. Bibliometric tools such as VOSviewer, CiteSpace, and Biblioshiny were used to analyze annual publication trends, co-authorship networks, country/institutional productivity, keyword co-occurrences, co-citation patterns, and citation bursts.</p><p><strong>Results: </strong>A marked increase in publication volume was observed after 2010, with the peak occurring in 2023. The United States led in both publication output and international collaboration. The Johns Hopkins School of Medicine, University of Wisconsin, and University of Utah were among the most productive institutions. Steven P. Cohen and Laxmaiah Manchikanti emerged as the most influential authors, centrally positioned within international co-authorship networks. Meanwhile, Pain Physician, Pain Medicine, and Regional Anesthesia and Pain Medicine were identified as the journals that exerted the greatest impact. Co-citation analysis revealed a thematic shift from early spinal facet interventions and diagnostic blocks toward peripheral applications, especially genicular nerve ablation, and consensus-based clinical practices. Keyword co-occurrence and citation burst analyses identified 3 chronological research themes: firstly, early spinal interventions (2000-2010), secondly, the diagnostic standardization era (2010-2017), and thirdly, expansion into peripheral, imaging-guided, and multidisciplinary applications (2017-2024).</p><p><strong>Limitations: </strong>The analysis was limited to English-language articles indexed in the WoSCC. Conference proceedings, book chapters, and articles from other databases were excluded. Therefore, some relevant studies might not have been captured.</p><p><strong>Conclusion: </strong>This bibliometric analysis demonstrates a steady growth in RFA-related publications globally. While spinal interventions remain the primary focus, an interest in peripheral applications has seen a notable increase. The expansion of RFA reflects both technological advancements and evolving clinical demands. Future studies should focus on long-term outcomes, clinica
背景:射频消融(RFA)是一种微创技术,越来越多地用于治疗肌肉骨骼疼痛,特别是当药物或康复方法证明不足时。然而,近20年来RFA的主题演变和研究进展并没有得到充分的探讨。目的:对全球关于肌肉骨骼疼痛的RFA文献进行全面的文献计量分析,确定2000年至2024年间的出版趋势、研究重点、主要贡献者和主题转换。研究设计:文献计量学分析。设置:数据从Web of Science Core Collection (WoSCC)中检索。方法:纳入2000年1月1日至2024年12月31日发表的736篇英文文章。文献计量工具如VOSviewer、CiteSpace和Biblioshiny用于分析年度出版趋势、合著网络、国家/机构生产力、关键词共现率、共被引模式和引文爆发。结果:2010年以后论文发表量明显增加,2023年达到高峰。美国在出版物产量和国际合作方面都处于领先地位。约翰霍普金斯医学院、威斯康辛大学和犹他大学是最具生产力的机构。Steven P. Cohen和Laxmaiah Manchikanti成为最有影响力的作者,在国际合作网络中处于中心位置。同时,《疼痛医师》、《疼痛医学》和《区域麻醉与疼痛医学》被确定为影响最大的期刊。共引分析揭示了从早期脊柱小关节干预和诊断阻滞到外周应用的主题转变,特别是膝神经消融和基于共识的临床实践。关键词共现和引文爆发分析确定了3个按时间顺序排列的研究主题:第一,早期脊柱干预(2000-2010),第二,诊断标准化时代(2010-2017),第三,扩展到周边,成像引导和多学科应用(2017-2024)。局限性:该分析仅限于在wscc中索引的英文文章。会议记录、书籍章节和其他数据库中的文章被排除在外。因此,一些相关的研究可能没有被捕获。结论:文献计量学分析表明全球rfa相关出版物稳步增长。虽然脊柱干预仍然是主要焦点,但对周边应用的兴趣已经显著增加。射频消融的扩大反映了技术的进步和不断变化的临床需求。未来的研究应侧重于长期结果、临床应用以及基于证据的脊柱和周围适应症治疗算法优化。
{"title":"Radiofrequency Ablation for Musculoskeletal Pain: A Bibliometric Analysis of Global Research Trends (2000-2024).","authors":"Sahide Eda Artuc, Gizem Kilinc Kamaci","doi":"","DOIUrl":"","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Radiofrequency ablation (RFA) is a minimally invasive technique increasingly utilized in the treatment of musculoskeletal pain, particularly when pharmacological or rehabilitative approaches prove insufficient. However, the thematic evolution and research development of RFA over the past 2 decades have not been explored adequately.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;To conduct a comprehensive bibliometric analysis of the global literature on RFA for musculoskeletal pain, identifying publication trends, research focuses, leading contributors, and thematic transitions between 2000 and 2024.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Study design: &lt;/strong&gt;Bibliometric analysis.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Setting: &lt;/strong&gt;Data were retrieved from the Web of Science Core Collection (WoSCC).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;A total of 736 English-language articles published between January 1, 2000, and December 31, 2024, were included. Bibliometric tools such as VOSviewer, CiteSpace, and Biblioshiny were used to analyze annual publication trends, co-authorship networks, country/institutional productivity, keyword co-occurrences, co-citation patterns, and citation bursts.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;A marked increase in publication volume was observed after 2010, with the peak occurring in 2023. The United States led in both publication output and international collaboration. The Johns Hopkins School of Medicine, University of Wisconsin, and University of Utah were among the most productive institutions. Steven P. Cohen and Laxmaiah Manchikanti emerged as the most influential authors, centrally positioned within international co-authorship networks. Meanwhile, Pain Physician, Pain Medicine, and Regional Anesthesia and Pain Medicine were identified as the journals that exerted the greatest impact. Co-citation analysis revealed a thematic shift from early spinal facet interventions and diagnostic blocks toward peripheral applications, especially genicular nerve ablation, and consensus-based clinical practices. Keyword co-occurrence and citation burst analyses identified 3 chronological research themes: firstly, early spinal interventions (2000-2010), secondly, the diagnostic standardization era (2010-2017), and thirdly, expansion into peripheral, imaging-guided, and multidisciplinary applications (2017-2024).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Limitations: &lt;/strong&gt;The analysis was limited to English-language articles indexed in the WoSCC. Conference proceedings, book chapters, and articles from other databases were excluded. Therefore, some relevant studies might not have been captured.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;This bibliometric analysis demonstrates a steady growth in RFA-related publications globally. While spinal interventions remain the primary focus, an interest in peripheral applications has seen a notable increase. The expansion of RFA reflects both technological advancements and evolving clinical demands. Future studies should focus on long-term outcomes, clinica","PeriodicalId":19841,"journal":{"name":"Pain physician","volume":"28 S7","pages":"S157-S168"},"PeriodicalIF":2.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145892852","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Comparison of Intraarticular Bipolar Pulsed Radiofrequency and Genicular Nerve Thermal Radiofrequency Ablation for Pain Caused by Osteoarthritis of the Knee. 关节内双极脉冲射频与膝神经热射频消融治疗膝关节骨性关节炎疼痛的比较。
IF 2.5 2区 医学 Q2 ANESTHESIOLOGY Pub Date : 2025-12-01
Cigdem Yalcin, Mehmet Alper Salman
<p><strong>Background: </strong>Information on the use of intraarticular bipolar pulsed radiofrequency (IA-bPRF) for treating knee osteoarthritis (KOA) is currently limited, and the effectiveness of this technique is not well established. The most effective nonsurgical approach for alleviating pain caused by KOA is still not well-defined.</p><p><strong>Objectives: </strong>Our aim was to investigate the effects of genicular radiofrequency (G-RFT) and IA-bPRF on pain relief and functional improvement in patients with advanced KOA.</p><p><strong>Study design: </strong>Records of 86 patients with KOA who received either G-RFT or IA-bPRF were evaluated retrospectively.</p><p><strong>Setting: </strong>The pain clinic of a state hospital.</p><p><strong>Methods: </strong>KOA patients who received either G-RFT or IA-bPRF were included in the study. The files of patients who were given such interventions between September 2021 and February 2024 were analyzed. Walking pain was evaluated on the numeric rating scale (NRS). Functional assessments were performed using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) and the Lequesne Algofunctional Index for Knee (LAI-knee). These evaluations were carried out before the intervention, as well as 2 weeks and 6 months after it.</p><p><strong>Results: </strong>The IA-bPRF group showed significant improvement in NRS scores when pre-intervention scores were compared to those recorded at the sixth month after the surgery, dropping from 8.62 ± 1.01 to 3.81 ± 1.18, while the scores of the G-RFT group improved from 8.90 ± 1.20 to 5.25 ± 3.40. At the sixth month, WOMAC scores decreased from 75.79 ± 16.00 to 34.21 ± 23.12 in the IA-bPRF group and from 79.02 ± 14.73 to 48.43 ± 30.87 in the G-RFT group. From the pre-intervention period to the sixth month after the procedure, LAI-knee scores went from 18.64 ± 4.16 to 9.90 ± 5.78 in the IA-bPRF group and from 18.89 ± 3.84 to 12.55 ± 7.33 in the G-RFT group. All decreases were significant (P < 0.05). However, WOMAC physical function scores decreased more in the IA-bPRF group than in the G-RFT group (P < 0.05). No serious adverse events occurred.</p><p><strong>Limitations: </strong>Our study is subject to several limitations. Primarily, there is a paucity of extensive literature regarding the application of IA-bPRF for KOA. Additionally, our study's sample size is relatively small. This study was conducted at a single center and was retrospective in nature, rather than prospective and randomized, making it challenging to fully control for nuisance variables. Finally, there is a scarcity of comparable studies. These factors may constrain the external validity of our findings.</p><p><strong>Conclusions: </strong>Pain incurred while walking on flat surfaces and up and down stairs was further reduced with IA-bPRF. IA-bPRF is as effective as G-RFT and even more effective than the latter in some subheadings. Furthermore, the former is a safe alternative for r
背景:目前关于关节内双极脉冲射频(IA-bPRF)治疗膝骨关节炎(KOA)的信息有限,该技术的有效性尚未得到很好的证实。缓解KOA引起的疼痛的最有效的非手术方法仍然没有明确的定义。目的:我们的目的是研究遗传射频(G-RFT)和IA-bPRF对晚期KOA患者疼痛缓解和功能改善的影响。研究设计:回顾性评价86例接受G-RFT或IA-bPRF治疗的KOA患者的记录。环境:国立医院的疼痛门诊。方法:将接受G-RFT或IA-bPRF治疗的KOA患者纳入研究。分析了2021年9月至2024年2月期间接受此类干预的患者档案。采用数字评定量表(NRS)对行走疼痛进行评定。使用西安大略和麦克马斯特大学骨关节炎指数(WOMAC)和膝关节Lequesne算法功能指数(LAI-knee)进行功能评估。这些评估在干预前以及干预后2周和6个月进行。结果:IA-bPRF组干预前NRS评分较术后6个月有明显改善,由8.62±1.01降至3.81±1.18,G-RFT组由8.90±1.20降至5.25±3.40。6个月时,IA-bPRF组WOMAC评分从75.79±16.00降至34.21±23.12,G-RFT组从79.02±14.73降至48.43±30.87。从干预前到手术后6个月,IA-bPRF组lai -膝关节评分从18.64±4.16上升到9.90±5.78,G-RFT组从18.89±3.84上升到12.55±7.33。均显著降低(P < 0.05)。IA-bPRF组WOMAC身体功能评分下降幅度大于G-RFT组(P < 0.05)。未发生严重不良事件。局限性:本研究存在一些局限性。首先,缺乏关于IA-bPRF在KOA中的应用的广泛文献。此外,我们的研究样本量相对较小。本研究在单中心进行,本质上是回顾性的,而不是前瞻性和随机的,因此很难完全控制有害变量。最后,缺乏可比较的研究。这些因素可能会限制我们研究结果的外部有效性。结论:IA-bPRF进一步减轻了在平面上行走和上下楼梯时产生的疼痛。IA-bPRF与G-RFT一样有效,在某些副标题中甚至比后者更有效。此外,前者是一个安全的选择,减轻疼痛和改善个人的日常生活与高级KOA。随着进一步的研究,IA-bPRF可能会被纳入治疗慢性KOA疼痛的未来指南中。
{"title":"The Comparison of Intraarticular Bipolar Pulsed Radiofrequency and Genicular Nerve Thermal Radiofrequency Ablation for Pain Caused by Osteoarthritis of the Knee.","authors":"Cigdem Yalcin, Mehmet Alper Salman","doi":"","DOIUrl":"","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Information on the use of intraarticular bipolar pulsed radiofrequency (IA-bPRF) for treating knee osteoarthritis (KOA) is currently limited, and the effectiveness of this technique is not well established. The most effective nonsurgical approach for alleviating pain caused by KOA is still not well-defined.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objectives: &lt;/strong&gt;Our aim was to investigate the effects of genicular radiofrequency (G-RFT) and IA-bPRF on pain relief and functional improvement in patients with advanced KOA.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Study design: &lt;/strong&gt;Records of 86 patients with KOA who received either G-RFT or IA-bPRF were evaluated retrospectively.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Setting: &lt;/strong&gt;The pain clinic of a state hospital.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;KOA patients who received either G-RFT or IA-bPRF were included in the study. The files of patients who were given such interventions between September 2021 and February 2024 were analyzed. Walking pain was evaluated on the numeric rating scale (NRS). Functional assessments were performed using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) and the Lequesne Algofunctional Index for Knee (LAI-knee). These evaluations were carried out before the intervention, as well as 2 weeks and 6 months after it.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;The IA-bPRF group showed significant improvement in NRS scores when pre-intervention scores were compared to those recorded at the sixth month after the surgery, dropping from 8.62 ± 1.01 to 3.81 ± 1.18, while the scores of the G-RFT group improved from 8.90 ± 1.20 to 5.25 ± 3.40. At the sixth month, WOMAC scores decreased from 75.79 ± 16.00 to 34.21 ± 23.12 in the IA-bPRF group and from 79.02 ± 14.73 to 48.43 ± 30.87 in the G-RFT group. From the pre-intervention period to the sixth month after the procedure, LAI-knee scores went from 18.64 ± 4.16 to 9.90 ± 5.78 in the IA-bPRF group and from 18.89 ± 3.84 to 12.55 ± 7.33 in the G-RFT group. All decreases were significant (P &lt; 0.05). However, WOMAC physical function scores decreased more in the IA-bPRF group than in the G-RFT group (P &lt; 0.05). No serious adverse events occurred.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Limitations: &lt;/strong&gt;Our study is subject to several limitations. Primarily, there is a paucity of extensive literature regarding the application of IA-bPRF for KOA. Additionally, our study's sample size is relatively small. This study was conducted at a single center and was retrospective in nature, rather than prospective and randomized, making it challenging to fully control for nuisance variables. Finally, there is a scarcity of comparable studies. These factors may constrain the external validity of our findings.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;Pain incurred while walking on flat surfaces and up and down stairs was further reduced with IA-bPRF. IA-bPRF is as effective as G-RFT and even more effective than the latter in some subheadings. Furthermore, the former is a safe alternative for r","PeriodicalId":19841,"journal":{"name":"Pain physician","volume":"28 S7","pages":"S179-S189"},"PeriodicalIF":2.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145892861","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2025 Index by Content. 2025按内容索引。
IF 2.5 2区 医学 Q2 ANESTHESIOLOGY Pub Date : 2025-12-01
Asipp
{"title":"2025 Index by Content.","authors":"Asipp","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":19841,"journal":{"name":"Pain physician","volume":"28 S7","pages":"S251-S268"},"PeriodicalIF":2.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145893070","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2025 Index by Key Words. 2025关键词指数。
IF 2.5 2区 医学 Q2 ANESTHESIOLOGY Pub Date : 2025-12-01
Asipp
{"title":"2025 Index by Key Words.","authors":"Asipp","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":19841,"journal":{"name":"Pain physician","volume":"28 S7","pages":"S275-S279"},"PeriodicalIF":2.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145893139","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2025 Index by Author. 2025作者索引。
IF 2.5 2区 医学 Q2 ANESTHESIOLOGY Pub Date : 2025-12-01
Asipp
{"title":"2025 Index by Author.","authors":"Asipp","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":19841,"journal":{"name":"Pain physician","volume":"28 S7","pages":"S269-S274"},"PeriodicalIF":2.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145893161","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Pain physician
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1